The development of technologies that allow the detection of circulating tumor cells, cell free DNA, or exosomes, combined with the advancements of sequencing technologies and the identification of novel biomarkers now allow more accurate detection and possible...
Diagnostics is hugely influencing disease treatment, management,and interventional prevention. The flood of findings is enormous, yet, not all of it is interpretable which produces a huge challenge not only for the test provider, but also for the physician and...
It was truly a pleasure to host this year’s soldout PMWC. As Dr. Keith Yamamoto (UCSF) noted in his presentation, “precision medicine: audacious aspiration, worthy outcomes.” It was nice to see that we are seeing the light at the end of the tunnel when it comes to...
They all have played and continue to play a tremendously critical role in shaping the human healthcare system, changing it from a general population approach to a personalized and patient-centered care model. For this reason, we honored these leaders for their...
Like a recurring theme, Illumina – when at JPMorgan Healthcare Conference -is contributing to some of the most clearly heard and most impactful announcements in the space. An obligatory new sequencer was released and along with that, the news of the launch of a...
The year 2015 is surely a success story for medicine and healthcare, starting early with the launch of the ambitious Precision Medicine Initiative (PMI) by the President in January during his State of the Union address. Since then, this year has brought us a flurry of...